Trans Ova Genetics, a global leader in bovine reproductive technologies, has announced a formal extension site collaboration with Target Genetics, formally AB Ireland, supporting the
establishment of advanced In Vitro Fertilization (IVF) laboratory capabilities in Ireland.
It is understood Target Genetics will implement IVF laboratory operations supported by Trans Ova Genetics’ proven protocols, proprietary IVF media, and comprehensive training
programs.
Setting standards
In a statement, Katie Jauert Jess, Chief Operating Officer at Trans Ova Genetics, said: “Trans Ova Genetics has invested decades into refining IVF processes, laboratory standards, and
embryology protocols.This collaboration reflects how we approach global growth at Trans Ova Genetics. Our Extension Site
model is designed to ensure consistency, quality, and integrity in IVF production, while empowering trusted partners to serve their local markets. By pairing Target Genetics’s regional expertise with Trans Ova’s training, media, and laboratory standards, we’re helping expand access to advanced reproductive technologies without compromising outcomes.”
Target Genetics
Commenting on the collaboration, Paddy Buckley, Managing Director of Target Genetics said: “Partnering with Trans Ova Genetics allows us to bring globally proven IVF systems and standards
directly to producers here in Ireland.This collaboration strengthens our ability to deliver consistent, high-quality IVF outcomes while
continuing to operate locally and responsively for our clients.”
Dr Paddy Buckley MRCVS at his lab in Co Cork. / Donal O'Leary
Having changed its namely recently from AB Ireland to Target Genetics, the Irish run business provides advanced bovine reproductive and genetic services to cattle breeders across
Ireland.
Through technologies including ovum pick-up (OPU), In Vitro Fertilisation (IVF), and embryo transfer, the company has been functioning for a number of years now, accelerating genetic improvement for both beef and dairy herds.
Trans Ova Genetics, a global leader in bovine reproductive technologies, has announced a formal extension site collaboration with Target Genetics, formally AB Ireland, supporting the
establishment of advanced In Vitro Fertilization (IVF) laboratory capabilities in Ireland.
It is understood Target Genetics will implement IVF laboratory operations supported by Trans Ova Genetics’ proven protocols, proprietary IVF media, and comprehensive training
programs.
Setting standards
In a statement, Katie Jauert Jess, Chief Operating Officer at Trans Ova Genetics, said: “Trans Ova Genetics has invested decades into refining IVF processes, laboratory standards, and
embryology protocols.This collaboration reflects how we approach global growth at Trans Ova Genetics. Our Extension Site
model is designed to ensure consistency, quality, and integrity in IVF production, while empowering trusted partners to serve their local markets. By pairing Target Genetics’s regional expertise with Trans Ova’s training, media, and laboratory standards, we’re helping expand access to advanced reproductive technologies without compromising outcomes.”
Target Genetics
Commenting on the collaboration, Paddy Buckley, Managing Director of Target Genetics said: “Partnering with Trans Ova Genetics allows us to bring globally proven IVF systems and standards
directly to producers here in Ireland.This collaboration strengthens our ability to deliver consistent, high-quality IVF outcomes while
continuing to operate locally and responsively for our clients.”
Dr Paddy Buckley MRCVS at his lab in Co Cork. / Donal O'Leary
Having changed its namely recently from AB Ireland to Target Genetics, the Irish run business provides advanced bovine reproductive and genetic services to cattle breeders across
Ireland.
Through technologies including ovum pick-up (OPU), In Vitro Fertilisation (IVF), and embryo transfer, the company has been functioning for a number of years now, accelerating genetic improvement for both beef and dairy herds.
SHARING OPTIONS